4
Changes in Ownership
CalciMedica, Inc. Filed Acc 0001415889-24-022503
Options or other derivatives
- Chief Scientific Officer acquired 62,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stauderman Kenneth A. Chief Scientific Officer | 2024-08-27 | Grant or award · Employee Stock Option (Right to Buy) | +62,500 | 62,500 | D | ||
Loading xslF345X05/form4-08282024_110845.xml…